Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 581-590 of 1154 total displayed.

Past content (since Jan 1999):

Clinical Investigations and Reports
Oxygen Free Radical Release in Human Failing Myocardium Is Associated With Increased Activity of Rac1-GTPase and Represents a Target for Statin Treatment
Christoph Maack, Tanja Kartes, Heiko Kilter, Hans-Joachim Schäfers, Georg Nickenig, Michael Böhm, and Ulrich Laufs
Circulation 2003;108:1567-1574; published online before print as doi:10.1161/01.CIR.0000091084.46500.BB [Abstract] [Full text]  

Articles
Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins
Koichi Shimizu, Masanori Aikawa, Kiyoshi Takayama, Peter Libby, and Richard N. Mitchell
Circulation published September 29, 2003, doi:10.1161/01.CIR.0000092949.67153.74 [Abstract]  

Clinical Investigations and Reports
Attenuation of Nitrate Tolerance and Oxidative Stress by an Angiotensin II Receptor Blocker in Patients With Coronary Spastic Angina
Nobutaka Hirai, Hiroaki Kawano, Hirofumi Yasue, Hideki Shimomura, Shinzo Miyamoto, Hirofumi Soejima, Ichiro Kajiwara, Tomohiro Sakamoto, Michihiro Yoshimura, Hajime Nakamura, Junji Yodoi, and Hisao Ogawa
Circulation 2003;108:1446-1450; published online before print as doi:10.1161/01.CIR.0000089092.61590.A8 [Abstract] [Full text]  

Clinical Investigations and Reports
Cholesterol Reduction With Atorvastatin Improves Walking Distance in Patients With Peripheral Arterial Disease
Emile R. Mohler, III, William R. Hiatt, Mark A. Creager for the Study Investigators
Circulation 2003;108:1481-1486; published online before print as doi:10.1161/01.CIR.0000090686.57897.F5 [Abstract] [Full text]  

Articles
Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes. Observations From the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Study
Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox, Feng Zhao, Basil S. Lewis, Steven L. Kopecky, Rafael Diaz, Patrick J. Commerford, Vicent Valentin, Salim Yusuf for the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) Trial Investigators
Circulation published September 22, 2003, doi:10.1161/01.CIR.0000091201.39590.CB [Abstract]  

Brief Rapid Communications
Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease: A Prospective Strain Rate Imaging Study
Frank Weidemann, Frank Breunig, Meinrad Beer, Joern Sandstede, Oliver Turschner, Wolfram Voelker, Georg Ertl, Anita Knoll, Christoph Wanner, and Jörg M. Strotmann
Circulation 2003;108:1299-1301; published online before print as doi:10.1161/01.CIR.0000091253.71282.04 [Abstract] [Full text]  

Clinical Investigations and Reports
Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
James E. Tcheng, David E. Kandzari, Cindy L. Grines, David A. Cox, Mark B. Effron, Eulogio Garcia, John J. Griffin, Giulio Guagliumi, Thomas Stuckey, Mark Turco, Martin Fahy, Alexandra J. Lansky, Roxana Mehran, and Gregg W. Stone
Circulation 2003;108:1316-1323; published online before print as doi:10.1161/01.CIR.0000087601.45803.86 [Abstract] [Full text]  

Review: Current Perspective
Ventricular Remodeling After Infarction and the Extracellular Collagen Matrix: When Is Enough Enough?
Bodh I. Jugdutt
Circulation 2003;108:1395-1403, doi:10.1161/01.CIR.0000085658.98621.49 [Full text]  

Articles
High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL Study
Scott Kinlay, Gregory G. Schwartz, Anders G. Olsson, Nader Rifai, Sally J. Leslie, William J. Sasiela, Michael Szarek, Peter Libby, Peter Ganz for the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Circulation published September 15, 2003, doi:10.1161/01.CIR.0000091404.09558.AF [Abstract]  

Articles
Selective Targeting and Timing of Matrix Metalloproteinase Inhibition in Post-Myocardial Infarction Remodeling
William M. Yarbrough, Rupak Mukherjee, G. Patricia Escobar, Joseph T. Mingoia, Jeffrey A. Sample, Jennifer W. Hendrick, Kathryn B. Dowdy, Julie E. McLean, Abigail S. Lowry, Timothy P. O'Neill, and Francis G. Spinale
Circulation published September 15, 2003, doi:10.1161/01.CIR.0000091087.78630.79 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment